Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
3,879,938
-
Shares change
-
-560,655
-
Total reported value, excl. options
-
$154,369,078
-
Value change
-
-$22,717,564
-
Number of buys
-
15
-
Number of sells
-
-51
-
Price
-
$39.83
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2019
84 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q2 2019.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,879,938 shares
.
Largest 10 shareholders include CREDIT SUISSE AG/ (1,173,600 shares), GOLDMAN SACHS GROUP INC (681,676 shares), MORGAN STANLEY (410,722 shares), JPMORGAN CHASE & CO (350,220 shares), DEUTSCHE BANK AG\ (350,000 shares), BANK OF AMERICA CORP /DE/ (130,233 shares), Wharton Business Group, LLC (104,880 shares), WELLS FARGO & COMPANY/MN (78,026 shares), Hochman Cole Investment Advisors, Inc. (71,793 shares), and LPL Financial LLC (48,170 shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.